Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

NURS 2514 > Pharmacology for neuromuscular > Flashcards

Pharmacology for neuromuscular Flashcards

1
Q

Neostigmine (Prostigmin) class

A

Cholinesterase inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Neostigmine (Prostigmin) MOA

A

Prevents degradation of acetylcholine by cholinesterase
Increases the amount of acetylcholine available to active receptors, thus increasing muscle strength
Improves impulse transmission at the neuromuscular junctions throughout the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is acetylcholinesterase?

A

Acetylcholinesterase is an enzyme that normally breaks down acetylcholine → Neostigmine binds to cholinesterase, taking it up the medication is broken down instead of acetylcholine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Neostigmine (Prostigmin) description

A

Therapeutic doses increase the force of muscle contraction. At toxic levels, the medication does the opposite and reduces the force of muscle contraction → cholinergic crises
Parasympathomimetic → acetylcholine is the primary neurotransmitter of the parasympathetic nervous system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Indications for neostigmine (Prostigmin)

A

Used as treatment for Myasthenia Gravis, reverses muscle relaxants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

neostigmine (Prostigmin) therapeutic effect

A

Improved muscle strength

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Additional info for neostigmine (Prostigmin)

A

Administered IV, IM, and Subcutaneous injection (poorly absorbed in the GI tract)
Does not cure Myasthenia Gravis but provides symptom relief
Lifelong use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Adverse effects of neostigmine (Prostigmin)

A

Excess acetylcholine → excessive salivation, increased gastric secretions, increased tone/ motility of GI tract, urinary urgency, bradycardia, and sweating, bronchial constriction
Toxic doses can cause accumulation of acetylcholine that leads to paralysis of respiratory muscles and worsened muscle weakness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cholinergic Crises

A

SLUDGE and the Killer Bs:
S: salivation
L: lacrimation
U: urination
D: diaphoresis/ diarrhea
G: gastrointestinal cramping
E: emesis

B: bradycardia
B: bronchospasm
B: bronchorrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Contraindications and precautions for neostigmine (Prostigmin)

A

Hypersensitivity
Bowel obstruction
Bladder obstruction
Cardiac issues → bradycardia, arrhythmias
Asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Nursing considerations and assessment for neostigmine (Prostigmin)

A

Monitor patient for improvement → increased ability to swallow and open eyelids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Nursing considerations and assessment for neostigmine (Prostigmin)

A

Monitor patient for improvement → increased ability to swallow and open eyelids
Patient may need to adjust dosage based on activity level (situational)
Assess patient for signs of underdosage (difficulty swallowing, ptosis) and overmedicating (excessive salivation, sweating, bradycardia, urinary urgency, increased GI motility, bronchoconstriction)
Monitor for Myasthenic crisis (under medicating) → extreme muscle weakness and
Monitor for cholinergic crisis (over medicating) → extreme muscle weakness and eventual paralysis and respiratory failure
Reversal agent for excessive muscarinic stimulation (cholinergic crisis) is Atropine
Patient should wear a medic alert bracelet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Myasthenic crisis vs cholinergic crisis

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The patient with myasthenia gravis is in suspected cholinergic crisis. Which medication do you anticipate the health care provider will order?

A

Anticholinergic (Atropine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Levodopa MOA

A

Crosses the blood brain barrier and converts to dopamine once it reaches the brain → thus restoring a balance between acetylcholine and dopamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Indications for levodopa

A

Parkinson’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Therapeutic effect of levodopa

A

Reduction in symptom severity, improvement in carrying out ADL’s
Does not cure PD or delay disease progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Additional info of levodopa

A

Administered orally
Therapeutic response can take several months
Most effective drug for PD
Effectiveness of Levodopa decreases over time (symptoms are usually well controlled in first 2 years of treatment and effectiveness declines)
A small fraction of medication reaches the brain when it is given alone, and for this reason, Levodopa is given in combination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Levodopa/ Carbidopa (Sinemet)

A

Carbidopa has no therapeutic effects on its own
When levodopa is taken on its own, only a small portion reaches the CNS → this requires high doses that lead to more side effects
Carbidopa delays the process of peripheral drug metabolism, allowing for more levodopa to enter the brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Adverse effects of levodopa/ carbidopa (Sinemet)

A

Nausea and vomiting → due to activation of dopamine receptors in the chemoreceptor trigger zone of the medulla
Dyskinesias → can cause movement disorders; tics, head bobbing, grimacing, rapid involuntary jerking, writhing movements, etc
Postural hypotension
Psychosis → visual hallucinations, vivid dreams, paranoia
CNS effects → anxiety, agitation, memory loss, cognitive impairment, issues with impulse control
Other side effects → can darken sweat and urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Precautions and contraindications of levodopa/ carbidopa (Sinemet)

A

Hypersensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Nursing considerations of levodopa/ carbidopa (Sinemet)

A

On/ Off phenomenon
Wearing-off phenomenon

Patients should avoid high protein meals → compete for absorption in gut
Assess for parkinsonian and extrapyramidal symptoms before and during therapy (shuffling gait, bradykinesia, drooling, pill rolling, tremors, twisting motions, masked face, rigidity)
Monitor blood pressure frequently during therapy
Patient should not transfer to a standing position abruptly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

pramipexole (Mirapex) classification

A

Nonergot dopamine receptor agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

pramipexole (Mirapex) MOA

A

Stimulates dopamine receptors in the striatum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Therapeutic effect of pramipexole (Mirapex)

A

Improve ability to carry out ADL’s → improvement in motor symptoms
Does not cure PD or delay progression of disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Additional info of pramipexole (Mirapex)

A

Used on its own in early PD
Used in combination with other Parkinson’s drugs in advanced PD
Effects take several weeks to develop
Given orally

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Adverse effects of pramipexole (Mirapex)

A

Associated with activating dopamine receptors → nausea, dizziness, sleepiness, confusion, hallucinations
When taken on its own, patients do not experience dyskinesias (abnormal movements)
When taken in combination with levodopa, the risk of developing orthostatic hypotension, hallucinations, and dyskinesias increases
“Sleep attacks” are overwhelming and irresistible sleepiness that come on without warning → ++ dangerous
Impulse control disorders → compulsive gambling, shopping, binge eating, hypersexuality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Nursing considerations & assessment of pramipexole (Mirapex)

A

Patients should be warned about potential to develop drowsiness → patients should not take sedating medications or alcohol while on pramipexole and should be asked about existing sleep disorders
Patients recently started on pramipexole should avoid driving or engaging in dangerous activities until they know whether it affects their wakefulness
If patient experiences sleep attacks, the medication should be discontinued
Monitor blood pressure regularly → advise patient to change positions slowly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Selegiline (Deprenyl) classification

A

MAO-B inhibitor

30
Q

What is MAO-B?

A

MAO-B is an enzyme that inactivates dopamine in the striatum

31
Q

MOA of selegiline (Deprenyl)

A

Selegiline is a selective inhibitor of MAO-B. When used in combination with Levodopa, it suppresses the destruction of dopamine derived from Levodopa, so can reduce wearing off effect

32
Q

Indication for selegiline (Deprenyl)

A

Parkinson’s Disease, depression

33
Q

Therapeutic effect of selegiline (Deprenyl)

A

Improvement in motor function
When used in combination with levodopa, can reduce wearing off effect

34
Q

Additional info for selegiline (Deprenyl)

A

This drug is often recommended for newly diagnosed PD → considered first-line drugs
May be used alone or in combination with Levodopa
Administered orally

35
Q

Adverse effects of selegiline (Deprenyl)

A

Insomnia (should not take after noon time)
Hypertensive crisis → if taken in high doses (increased risk with younger people)

36
Q

Drug interactions with selegiline (Deprenyl)

A

In combination with Levodopa, will worsen orthostatic hypotension, dyskinesia, and psychiatric symptoms
Should not be taken with meperidine or selective serotonin reuptake inhibitors (SSRIs)

37
Q

Nursing considerations and assessment for selegiline (Deprenyl)

A

Assess gait and motor function to assess effectiveness of treatment and identity dyskinesia side effects of medication
Monitor patient for changes in behaviour and psychiatric symptoms
If used in combination with Levodopa, monitor blood pressure and discuss risk for falls

38
Q

Anticholinergics MOA

A

Block action of acetylcholine
Other treatments directly affect dopamine, whereas anticholinergics work on correcting the imbalance by focusing on acetylcholine
Often used in combination with other antiparkinsonian medications

39
Q

The goal of Parkinson’s Disease pharmacotherapy is:
a. To increase the amount of acetylcholine at the presynaptic neurons
b. To reduce the amount of dopamine available in the substantia nigra
c. To balance cholinergic and dopaminergic activity in the brain
d. To block dopamine receptors in presynaptic and postsynaptic neurons

A

c. To balance cholinergic and dopaminergic activity in the brain

40
Q

A patient with Parkinson’s disease who has been positively responding to drug treatment with levodopa/ carbidopa (Sinemet) suddenly develops a relapse of symptoms. What is this called?

A

Wearing-off (WO) phenomenon is a frequent complication which is defined as a reoccurrence of motor and non-motor symptoms during levodopa free interval, which has a negative impact on the quality of life of patients.

41
Q

Which statement should the nurse include in the teaching plan for a patient being started on levodopa/ carbidopa (Sinemet) for newly diagnosed Parkinson’s disease?
a. Take the medication on a full stomach
b. Change positions slowly
c. The drug may cause the urine to be very dilute
d. Carbidopa has many adverse effects

A

b. Change positions slowly

42
Q

Interferon beta drugs (Betaseron) classification

A

Immunomodulator

43
Q

Interferon beta drugs (Betaseron) MOA

A

Naturally occurring glycoprotein
Inhibits migration of proinflammatory leukocytes across the blood brain barrier (cannot reach neurons of the CNS)
Suppresses t-helper cell activity

44
Q

Indication for interferon beta drugs (Betaseron)

A

Multiple sclerosis

45
Q

Therapeutic effect of interferon beta drugs (Betaseron)

A

Can decrease the frequency and severity of relapse, reduce the size and number of lesions, and delay progression of disability

46
Q

Additional info for interferon beta drugs (Betaseron)

A

Intramuscular or subcutaneous → depends on the specific drug

47
Q

Adverse effects of interferon beta drugs (Betaseron)

A

Flu-like symptoms → headache, fever, chills, malaise, muscle aches, and stiffness (this decreases over time and can be minimized by starting on lower doze and gradually increasing, as well as taking tylenol)
Hepatoxicity → can damage liver cells
Myelosuppression → can suppress bone marrow function, decreasing production of all blood cells
Depression and suicidal ideation

48
Q

Contraindications of interferon beta drugs (Betaseron)

A

Hypersensitivity
Patients with previous suicide attempts and depression → use cautiously
Patients with liver disease and alcoholism → use cautiously

49
Q

Drug interactions for interferon beta drugs (Betaseron)

A

Should not combine with alcohol or other hepatotoxic medications
Should not take with other immunosuppressants

50
Q

Nursing considerations and assessment for interferon beta drugs (Betaseron)

A

Assess for MS symptoms during therapy
Monitor liver function tests and CBC (hgb, platelets, WBC) → prior to treatment and at 1, 3, and 6 month
Monitor for signs of depression
Educate patient about likelihood of experiencing flu like symptoms and offer acetaminophen for relief
Educate about the signs of depression, suicidal ideation, and worsening anxiety

51
Q

Classification of mitoxantrone (Novantrone)

A

Immunosuppressant
Cytotoxic drug → this means it kills cells in the body

52
Q

Mitoxantrone (Novantrone) MOA

A

It binds with DNA and inhibits DNA and RNA synthesis, causing breakage of DNA strands
Like chemotherapy, Mitoxantrone is more lethal to cells that divide fast → hair, skin, GI mucosa, and bone marrow
Suppresses production of immune system cells and decreases immune system cells and decreases immune system destruction of myelin

53
Q

Indication for mitoxantrone (Novantrone)

A

Was developed to treat cancer, but can be used for MS

54
Q

Therapeutic effect of mitoxantrone (Novantrone)

A

It can delay MS patients going into relapse, delays disability progression, and can decrease lesions

55
Q

Adverse effects of mitoxantrone (Novantrone)

A

Myelosuppression → toxic to bone marrow cells causing decreased platelets, white blood cells, and red blood cells. Reduced neutrophils leads to high risk of infection
Cardiotoxicity → affects left ventricular ejection fraction and can cause heart failure. This can occur months to years after treatment has ended
Teratogenic → potential for fetal harm
Hair loss, nausea/ vomiting, and mouth sores → all related to the death of rapidly dividing cells

56
Q

Contraindications of mitoxantrone (Novantrone)

A

Hypersensitivity
Use cautiously in patients with cardiac diseases
Use cautiously in patients with active infections

57
Q

Nursing considerations and assessments for mitoxantrone (Novantrone)

A

Monitor for bone marrow depression (bleeding and bruising due to decreased platelets, signs of infection due to decreased neutrophils, signs of anemia due to decreased red blood cells)
Monitor for GI symptoms → administer antiemetics prophylactically
Inspect mouth for sores
Assess fluid and electrolytes, intake, output, appetite, nutrition
Patients should have baseline EKG, chest x-ray, and echo to determine ejection fraction and cardiac status prior to starting therapy and during therapy
Assess for signs of heart failure (auscultate lungs for crackles, assess edema, shortness of breath, chest pain)
IV administration → CAREFUL with handling
Monitor patient IV site carefully - infusion to be stopped if patient develops pain, swelling, redness

58
Q

Baclofen (Lioresel) classification

A

Skeletal muscle relaxant

59
Q

Baclofen (Lioresel) MOA

A

Acts within the spinal cord (CNS) to suppress hyperactive reflexes involved in the regulation of muscle movement
Structural analog of the inhibitory NT GABA (mimics actions of GABA on spinal neurons)

60
Q

Indication for baclofen (Lioresel)

A

Used to relieve muscle spasticity with MS and spinal cord injury

61
Q

Therapeutic effect of baclofen (Lioresel)

A

Relieve muscle spasticity
Decrease flexor and extensor spasms and suppresses resistance to passive movement

62
Q

Administration of baclofen (Lioresel)

A

PO, intrathecal (a pump surgically placed directly into the spinal fluid of the back)

63
Q

Adverse effects of baclofen (Lioresel)

A

CNS depressants: drowsiness, dizziness, weakness, and fatigue (improves over time with longterm use)
Withdrawal symptoms from stopping abruptly (hallucinations, seizures, paranoid ideation. Intrathecal route has a higher risk of severe symptoms (fever, muscle rigidity, exaggerated rebound spasticity, multi-organ failure, death))
Nausea and vomiting
Constipation, urinary retention
Orthostatic hypotension

64
Q

Nursing considerations and assessment for baclofen (Lioresel)

A

Extreme caution with other CNS depressants (ETOH, antihistamines, opioids, benzodiazepines)
-Overdose or combination with other CNS depressants can cause respiratory depression

Overdose
-Respiratory depression
-NO ANTIDOTE

Monitor for withdrawal symptoms
Intrathecal route
-monitor infusion system closely

65
Q

Gabapentin (Neurontin) classification

A

GABA analog (antiseizure agent)

66
Q

Gabapentin (Neurontin) MOA

A

Gabapentin is an analog of GABA but does not directly affect GABA receptors. Its precise mechanism of action is unknown, but it may enhance GABA release, thereby increasing GABA-mediated inhibition of neuronal firing

67
Q

Indications for gabapentin (Neurontin)

A

Gabapentin also has approval for treating postherpetic neuralgia
Most used for off-label uses, including relief of neuropathic pain (other than postherpetic neuralgia)

68
Q

Adverse effects of gabapentin (Neurontin)

A

Gabapentin is very well tolerated
The most common side effects are somnolence, dizziness, ataxia, fatigue, nystagmus, and peripheral edema. These are usually mild to moderate and often diminish with continued drug use
Caution with other CNS depressants
Mood changes, suicidal ideation
Withdrawal symptoms with abrupt discontinuation

69
Q

Contraindication for gabapentin (Neurontin)

A

Hypersensitivity

70
Q

Nursing considerations and assessment for gabapentin (Neurontin)

A

Monitor for signs of CNS depression
Improvement of neuropathic pain
Monitor for changes in good, depression, suicidal ideation

NURS 2514 (14 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions